[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL210410A1 - Sposob wytwarzania kompleksu nowych antybiotykow dezoksynarasynowych - Google Patents

Sposob wytwarzania kompleksu nowych antybiotykow dezoksynarasynowych

Info

Publication number
PL210410A1
PL210410A1 PL21041078A PL21041078A PL210410A1 PL 210410 A1 PL210410 A1 PL 210410A1 PL 21041078 A PL21041078 A PL 21041078A PL 21041078 A PL21041078 A PL 21041078A PL 210410 A1 PL210410 A1 PL 210410A1
Authority
PL
Poland
Prior art keywords
deosoxinarasin
antibotics
complex
manufacturing
new
Prior art date
Application number
PL21041078A
Other languages
English (en)
Other versions
PL117570B1 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PL210410A1 publication Critical patent/PL210410A1/pl
Publication of PL117570B1 publication Critical patent/PL117570B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • C12R2001/485Streptomyces aureofaciens
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces
    • Y10S435/889Streptomyces aureofaciens

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
PL1978210410A 1977-10-20 1978-10-20 Method of manufacture of complex of novel desoxynarasynic antibioticsantibiotikov PL117570B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/844,087 US4141907A (en) 1977-10-20 1977-10-20 Deoxynarasin antibiotics

Publications (2)

Publication Number Publication Date
PL210410A1 true PL210410A1 (pl) 1979-10-22
PL117570B1 PL117570B1 (en) 1981-08-31

Family

ID=25291778

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1978210410A PL117570B1 (en) 1977-10-20 1978-10-20 Method of manufacture of complex of novel desoxynarasynic antibioticsantibiotikov

Country Status (33)

Country Link
US (1) US4141907A (pl)
EP (1) EP0001709B1 (pl)
JP (1) JPS5470276A (pl)
AR (1) AR217869A1 (pl)
AT (1) AT362499B (pl)
AU (1) AU519966B2 (pl)
BE (1) BE871274A (pl)
CA (1) CA1119541A (pl)
CH (1) CH636903A5 (pl)
CS (1) CS204037B2 (pl)
DD (1) DD139520A5 (pl)
DE (1) DE2861882D1 (pl)
DK (1) DK465978A (pl)
ES (1) ES474327A1 (pl)
FI (1) FI58791C (pl)
FR (1) FR2406639A1 (pl)
GB (1) GB2006774B (pl)
GR (1) GR71734B (pl)
HU (1) HU179463B (pl)
IE (1) IE47665B1 (pl)
IL (1) IL55738A (pl)
IT (1) IT1101615B (pl)
MX (1) MX5603E (pl)
MY (1) MY8500595A (pl)
NO (1) NO783545L (pl)
NZ (1) NZ188670A (pl)
PH (1) PH14339A (pl)
PL (1) PL117570B1 (pl)
PT (1) PT68661A (pl)
RO (1) RO77417A (pl)
SU (1) SU818492A3 (pl)
YU (1) YU241578A (pl)
ZA (1) ZA785804B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2024806B (en) * 1978-03-16 1982-05-06 Taisho Pharmaceutical Co Ltd Onomycin derivatives
IE49936B1 (en) * 1979-07-11 1986-01-08 Int Minerals & Chem Corp Zinc-containing antibiotic agents
US4309504A (en) * 1980-01-28 1982-01-05 Eli Lilly And Company Process for preparing narasin
US4394377A (en) * 1981-07-31 1983-07-19 Syntex (U.S.A.) Inc. Ruminant animal performance by co-administering choline and propionate enchancers
US4625041A (en) * 1984-02-17 1986-11-25 Pfizer Inc. Acidic polycyclic ether antibiotic
US4859599A (en) * 1984-10-11 1989-08-22 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
US4613503A (en) * 1984-10-11 1986-09-23 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
US5049495A (en) * 1986-05-29 1991-09-17 International Minerals & Chemical Corp. Fermentation method for producing polyether antibiotics
US5047338A (en) * 1986-05-29 1991-09-10 International Minerals & Chemical Corp. Polyester Antibiotic preparation
US5041374A (en) * 1986-05-29 1991-08-20 International Minerals & Chemical Corp. Polyether antibiotic recovery and purification
WO2008033466A2 (en) * 2006-09-14 2008-03-20 Combinatorx (Singapore) Pre. Ltd. Compositions and methods for treatment of viral diseases
CN108743905A (zh) * 2018-08-24 2018-11-06 河南科技大学第附属医院 一种治疗感冒的中药配方及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753887A (en) 1969-06-04 1973-08-21 Hydronautics Alkali metal specific measuring electrode
US3947586A (en) 1974-05-20 1976-03-30 Hoffmann-La Roche Inc. Method of combatting swine dysentery
US4038384A (en) * 1974-06-10 1977-07-26 Eli Lilly And Company Antibiotic a-28086 and process for production thereof
US3985893A (en) 1974-10-29 1976-10-12 Eli Lilly And Company Method for treating cardiac insufficiency with antibiotic A-23187
US4009262A (en) 1975-04-21 1977-02-22 Eli Lilly And Company Antibiotic a-28086 recovery process
US4035481A (en) 1975-04-21 1977-07-12 Eli Lilly And Company Antibiotic A-28086 and process for production thereof

Also Published As

Publication number Publication date
JPS5470276A (en) 1979-06-05
ATA750778A (de) 1980-10-15
MX5603E (es) 1983-11-07
AT362499B (de) 1981-05-25
DE2861882D1 (en) 1982-07-22
DK465978A (da) 1979-06-15
IE47665B1 (en) 1984-05-16
GB2006774A (en) 1979-05-10
IL55738A0 (en) 1978-12-17
HU179463B (en) 1982-10-28
CA1119541A (en) 1982-03-09
GB2006774B (en) 1982-09-02
CS204037B2 (en) 1981-03-31
FI783174A (fi) 1979-04-21
CH636903A5 (fr) 1983-06-30
EP0001709B1 (en) 1982-06-02
YU241578A (en) 1982-10-31
ZA785804B (en) 1980-05-28
EP0001709A3 (en) 1979-05-16
PH14339A (en) 1981-05-29
NZ188670A (en) 1981-05-29
IT1101615B (it) 1985-10-07
SU818492A3 (ru) 1981-03-30
FI58791B (fi) 1980-12-31
GR71734B (pl) 1983-06-22
MY8500595A (en) 1985-12-31
FR2406639B1 (pl) 1981-08-14
PT68661A (en) 1978-11-01
IT7828926A0 (it) 1978-10-19
AU519966B2 (en) 1982-01-07
PL117570B1 (en) 1981-08-31
EP0001709A2 (en) 1979-05-02
BE871274A (fr) 1979-04-17
FI58791C (fi) 1981-04-10
JPS6244553B2 (pl) 1987-09-21
DD139520A5 (de) 1980-01-09
IE782078L (en) 1979-04-20
AU4077678A (en) 1980-04-24
RO77417A (ro) 1981-11-04
FR2406639A1 (fr) 1979-05-18
US4141907A (en) 1979-02-27
AR217869A1 (es) 1980-04-30
ES474327A1 (es) 1979-11-01
NO783545L (no) 1979-04-23
IL55738A (en) 1981-10-30

Similar Documents

Publication Publication Date Title
PL208407A1 (pl) Sposob wytwarzania interferonu
PL211164A1 (pl) Sposob wytwarzania nowych peptydow
PL207835A1 (pl) Sposob etylowania monoalkilobenzenu
PL202305A1 (pl) Sposob wytwarzania furanokumaryny
PL207887A1 (pl) Sposob wytwarzania parabenzochinonu
PL210410A1 (pl) Sposob wytwarzania kompleksu nowych antybiotykow dezoksynarasynowych
PL204616A1 (pl) Sposob wytwarzania pochodnych 1-oksadetiacefamowych
PL205592A1 (pl) Sposob wytwarzania nitrozobenzenu
PL208543A1 (pl) Sposob wytwarzania nowych imidazoizochinolinodionow
PL208496A1 (pl) Sposob wytwarzania nowych peptydow
PL207592A1 (pl) Sposob wytwarzania nowych pirydazynylohydrazonow
PL204428A1 (pl) Sposob wytwarzania nowych pochodnych erytomycyny
PL209329A1 (pl) Sposob wytwarzania 2-chlorosulfinyloazetydynonow-4
PL198559A1 (pl) Sposob wytwarzania dwu-n-propylo-acetonitrylu
PL205590A1 (pl) Sposob wytwarzania 2-hydroksybenzotiazoli
PL210932A1 (pl) Sposob wytwarzania tiolokarbaminianow
PL204964A1 (pl) Sposob wytwarzania akantomycyny
IT7850748A0 (it) Produzione di n-acil-tienamicine
PL205160A1 (pl) Sposob wytwarzania chlorotiomrowczanu etylu
PL201626A1 (pl) Sposob wytwarzania trojchlorobenzenow
PL201625A1 (pl) Sposob wytwarzania trojchlorobenzenow
PL198669A1 (pl) Sposob wytwarzania chlorocyjanu
PL201824A1 (pl) Sposob wytwarzania m-benzoiloacetofenonu
PL203319A1 (pl) Sposob wytwarzania katalizatorow
PL201971A1 (pl) Sposob otrzymywania chlorowcoarylofosforanow